How to Compare Direct-to-Consumer Perimenopause Testing Companies
Four criteria can separate useful perimenopause tests from misleading ones.
Four criteria can separate useful perimenopause tests from misleading ones.
Baseline bone scans work best before perimenopause's steepest losses.
You can use pretax HSA and FSA dollars to pay for at-home hormone testing.
CGM reveals insulin resistance that standard blood tests miss during perimenopause.
Wearables detect hot flashes but lack clinical proof of what the signal actually means.
Wearables track symptoms, not the hormones driving them.
A symptom log and clinical framing help patients navigate insurer and physician barriers to testing.
Supplement companies exploit a gap in menopause care to sell unproven treatments with vague claims.
AMH and repeated FSH testing replace the cycle-day protocol when periods turn unpredictable.
Hormonal swings during perimenopause shift lipid profiles in ways the standard panel cannot detect.
Ferritin testing reveals iron depletion that standard blood counts miss in women with heavy periods.